Tektrotyd is a SPECT/CT alternative for diagnosing GEP-NET tumours that overexpresses somatostatinreceptors. It is a kit for the radiopharmaceutical preparation of 99mTc.
Kit for the preparation of 99mTc-TEKTROTYD used for intravenous injection after radiolabelling with sodium 99mTc pertechnetate solution and is indicated for diagnostics of pathological lesions in which somatostatin receptors are overexpressed (particularly subtype 2 and, to a less extent, subtypes 3 and 5).
In particular, these are:
- Gastro-entero-pancreatic neuroendocrine tumours (GEP-NET)
- Pituitary adenomas
- Tumours originating in a sympathetic system; pheochromocytoma, paraganglioma, neuroblastoma, ganglioneurinoma etc.
- Medullary thyroid carcinoma
This kit is a registered pharmaceutical since 2016.
Information for HCP
Follow the link to your local SmPC
Tektrotyd is manufactured by Polatom and is distributed in the Nordic region by SAM Nordic.